Investors’ Big Bet on GE

A recent article in The Wall Street Journal reports that General Electric Co.’s agreement earlier this month to sell a small but rapidly-growing biotechnology business for $21 billion “provided a moment of validation to a group of value-seeking stock buyers who plowed into the stock at the end of 2018 amid fears the company was collapsing.” The article reports that, in the fourth quarter of 2018, “investors who seek undervalued or misunderstood stocks turned toward… Read More